In vitro and in vivo activity and pathophysiology of human interleukin-8 and related peptides.
Interleukin-8 is a member of a novel cytokine family and has been found to be an activator and attractant for human neutrophils in vitro. The in vivo activity was tested in experimental animal models by intradermal and intravenous administration of IL-8. Intradermal administration of human IL-8 in rats induces a rapid and concentration-dependent neutrophil infiltration, which peaks 4 hr after IL-8 application. Injection of GRO-alpha induces a similar chemotactic response, whereas neutrophil-activating peptide-2 was significantly less active. When injected intravenously into rabbits, IL-8 induced neutrophil sequestration in the lungs and, following repeated injections, caused septal and intraalveolar edema and lung damage resembling that seen in adult respiratory distress syndrome. The fact that IL-8 is induced and secreted from many different cell types suggests its involvement in a variety of physiologic and pathologic conditions as a neutrophil chemoattractant and, possibly, as an activator of other neutrophil responses.
Zwahlen
R
R
Institut für Tierpathologie, Universität Bern, Switzerland.
Walz
A
A
Rot
A
A
D000818:Animals; D002478:Cells, Cultured; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D006801:Humans; D007249:Inflammation / Q000139:chemically induced; D007271:Injections, Intradermal; D016209:Interleukin-8 / Q000494:pharmacology / Q000633:toxicity*; D007962:Leukocytes / Q000187:drug effects; D008297:Male; D009504:Neutrophils / Q000187:drug effects; D010455:Peptides / Q000494:pharmacology / Q000633:toxicity*; D011654:Pulmonary Edema / Q000139:chemically induced; D011817:Rabbits; D051381:Rats; D017208:Rats, Wistar; D011994:Recombinant Proteins / Q000633:toxicity; D001620:beta-Thromboglobulin
D016209:Interleukin-8; C061615:PPBP protein, human; D010455:Peptides; D011994:Recombinant Proteins; D001620:beta-Thromboglobulin; C009862:connective tissue-activating peptide